Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net income available to common stockholders	$ 79,058	$ 66,267
(Loss) income from discontinued operations	0	1,544
Income from continuing operations	79,058	64,723
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	19,192	23,958
Stock compensation expense	5,889	6,769
Exit activity costs, non-cash	1,427	1,193
Provision for (benefit of) deferred income taxes	181	(689)
Other, net	3,620	1,274
Changes in operating assets and liabilities, excluding the effects of acquisitions:
Accounts receivable	(25,538)	(65,297)
Inventories	(19,840)	(65,906)
Other current assets and other assets	393	(316)
Accounts payable	(24,756)	32,029
Accrued expenses and other non-current liabilities	(1,065)	(12,261)
Net cash provided by (used in) operating activities of continuing operations	38,561	(14,523)
Net cash used in operating activities of discontinued operations	0	(2,002)
Net cash provided by (used in) operating activities	38,561	(16,525)
Cash Flows from Investing Activities
Purchases of property, plant, and equipment	(15,704)	(13,251)
Acquisitions, net of cash acquired	(51,621)	4,143
Net proceeds from sale of business	0	38,062
Net cash (used in) provided by investing activities of continuing operations	(67,325)	28,954
Net cash used in investing activities of discontinued operations	0	(176)
Net cash (used in) provided by investing activities	(67,325)	28,778
Cash Flows from Financing Activities
Proceeds from long-term debt	197,800	58,500
Long-term debt payments	(100,000)	(83,636)
Purchase of common stock at market prices	(58,125)	(6,161)
Net proceeds from issuance of common stock	0	1,021
Net cash provided by (used in) financing activities	39,675	(30,276)
Effect of exchange rate changes on cash	(1,841)	(97)
Net increase (decrease) in cash and cash equivalents	9,070	(18,120)
Cash and cash equivalents at beginning of year	12,849	32,054
Cash and cash equivalents at end of period	$ 21,919	$ 13,934